EX-23.2 13 dna-20251231xex232.htm EX-23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1.Registration Statement (Form S-8 No. 333-277558) pertaining to the Ginkgo Bioworks Holdings, Inc. 2021 Incentive Award Plan and 2021 Employee Stock Purchase Plan
2.Registration Statement (Form S-3 Nos. 333-279280, 333-274171, 333-269443, 333-267743, 333-267315, 333-258712, 333-261318, 333-264129 and 333-289390) of Ginkgo Bioworks Holdings, Inc.,
3.Registration Statement (Form S-8 No. 333-270506) pertaining to the Ginkgo Bioworks Holdings, Inc. 2021 Incentive Award Plan and 2021 Employee Stock Purchase Plan,
4.Registration Statement (Form S-8 No. 333-261205) pertaining to the Ginkgo Bioworks Holdings, Inc. 2021 Incentive Award Plan, 2021 Employee Stock Purchase Plan, 2014 Stock Incentive Plan and 2008 Stock Incentive Plan,
5.Registration Statement (Form S-8 No. 333-267952) pertaining to the Ginkgo Bioworks Holdings, Inc. 2021 Incentive Award Plan and 2022 Inducement Plan, and
6.Registration Statement (Form S-8 No. 333-285235) pertaining to the Ginkgo Bioworks Holdings, Inc. 2021 Incentive Award Plan and 2021 Employee Stock Purchase Plan;
of our report dated February 29, 2024 (except for note 16 and the effects of the reverse stock split described in note 2, as to which the date is February 25, 2025), with respect to the consolidated financial statements of Ginkgo Bioworks Holdings, Inc. included in this Annual Report (Form 10-K) of Ginkgo Bioworks Holdings, Inc. for the year ended December 31, 2025.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 26, 2026